Featured news
All news
Showing 20 results

2025 East Paediatric Genomics Forums
We're continuing our popular East Paediatric Genomics Forum into 2025 with two great sessions for January and February.

Nurses leading first-of-its-kind cancer genomics service
Two nurses are leading a first-of-its-kind genomics service for cancer patients in the East of England.

Event leads to recommendations to increase access to whole genome sequencing for children with cancer
A workshop event, organised by the CRUK Cambridge Centre Paediatric Cancer Programme, University of Cambridge Department of Paediatrics, NHS East Genomics, Wellcome Sanger Institute and Wellcome Connecting Science has led to an important series of recommendations for improving equity of access to whole genome sequencing (WGS) for children with cancer across the UK.

Cambridge scientists win Sarcoma UK award for ‘transformative’ genomics study
A research team from East Genomics have been presented with the Sarcoma UK Shining Research of the Year Award

East Region Prenatal Genomics Forum, 16 December 2024
Our next Prenatal Genomics Forum takes place on Monday 16 December 2024 at 1pm.

Our November 2024 newsletter
Our latest East Genomics newsletter is out now.

Funding available to set up a genomics Community of Practice
We are seeking expressions of interest from clinicians for new genomics Communities of Practice (COPs), with funding and support available.

Nov 2024 East Paediatric Genomics Forum: The Generation Study
Join us on Thursday 28 November from 12.30pm - 1.30pm for our Paediatric Genomics Forum on The Generation Study in the East GMSA region.

Our new genomics e-learning platform launched
We are thrilled to announce the launch of our new genomics e-learning platform.

Real time DNA analysis for brain tumours could guide surgeons as they operate
A team spanning neuropathologists, scientists, neurosurgeons and researchers at Nottingham University Hospitals NHS Trust (NUH), the University of Nottingham and colleagues in Germany is developing a nanopore sequencing-based approach that has the potential to transform the diagnosis of tumours.

Webinar: Clopidogrel use after ischaemic stroke or transient ischaemic attack
Genetic testing in patients who have had a stroke can be an effective tool in assessing whether clopidogrel is an appropriate treatment to prevent further strokes.

Our October 2024 newsletter out now!
Our latest East Genomics newsletter is out now.

More patients in the East to benefit from personalised breast cancer treatment
A ground-breaking breast cancer programme pioneered at Addenbrooke’s Hospital, which decodes the genetic sequence of a patient’s cancer is to expand in the East.

Largescale study of children with genetic disorders finds huge benefits of diagnosis
For Lisa Hawker, getting a diagnosis of her daughter Jaydi’s rare genetic condition was life-saving.

New app launched to support estimated 175,000 people in the UK with Lynch Syndrome
A new app has been launched to help people living with Lynch Syndrome to monitor and manage their condition, alongside their treating clinicians.

First newborn babies tested for over 200 genetic conditions as world-leading study begins in NHS hospitals
Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.

Whole Genome Sequencing at Birth: Implementing the Generation Study
A free-to-attend online event discussing the Generation Study – an NHS-embedded research study which is sequencing the whole genomes of 100,000 newborn babies, in order to understand whether we can improve our ability to diagnose and treat genetic conditions.

Our September 2024 newsletter out now!
Our latest East Genomics newsletter is out now.

Research and Innovation job opportunities
We are recruiting to two new roles in the research and innovation space.

Specialist Paediatric Workshop - 'Condition Suspected' Pathway of the Generation Study
A Generation Study Workshop, hosted by the East GMSA with a short presentation from representatives of Genomics England's Generation Study.